Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       


Value Line® Target 25 Portfolio, 2nd Quarter 2019 Series
Ticker Symbol: FSORGX

25 Holdings (As of Day of Deposit)
Ticker Company Name Initial
AMT American Tower Corporation 7.04% $196.22
AZO AutoZone, Inc. 2.12% 1,052.54
BLL Ball Corporation 1.58% 58.20
BKH Black Hills Corporation 1.01% 72.65
BAH Booz Allen Hamilton Holding Corporation 1.00% 58.34
CABO Cable One, Inc. 1.02% 1,011.19
CDNS Cadence Design Systems, Inc. 1.47% 63.98
CWT California Water Service Group 1.01% 50.93
CIEN Ciena Corporation 1.01% 37.24
DG Dollar General Corporation 2.59% 122.30
LLY Eli Lilly and Company 10.69% 127.16
EPAM EPAM Systems, Inc. 1.02% 169.27
FICO Fair Isaac Corporation 1.00% 275.45
GRMN Garmin Ltd. 1.37% 89.10
GIL Gildan Activewear Inc. 1.01% 36.63
HCA HCA Healthcare, Inc. 3.75% 131.84
IPAR Inter Parfums, Inc. 1.01% 76.89
INTU Intuit Inc. 5.52% 260.76
MRK Merck & Co., Inc. 17.04% 80.95
PG The Procter & Gamble Company 21.11% 104.97
SHEN Shenandoah Telecommunications Company 1.00% 43.93
SBUX Starbucks Corporation 7.60% 75.20
VRSN VeriSign, Inc. 1.84% 189.77
WM Waste Management, Inc. 3.54% 102.09
XLNX Xilinx, Inc. 2.65% 129.90

*As of the close of business on 4/8/19. Market values are for reference only and are not indicative of your individual cost basis. Holdings were selected by applying each strategy as described in the prospectus.

Not FDIC Insured • Not Bank Guaranteed • May Lose Value
Portfolio Summary
Initial Offering Date 4/10/2019
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 7/9/2020
Cash CUSIP 30297W181
Reinvestment CUSIP 30297W199
Fee Accounts Cash CUSIP 30297W207
Fee Accounts Reinvestment CUSIP 30297W215

Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges: Initial: 0.00%
  Deferred: 1.35%
Creation & Development Fee:   0.50%
Maximum Sales Charge:   1.85%

The deferred sales charge will be deducted in three monthly installments commencing 7/19/19.

When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge.

Fee/Wrap Accounts
Maximum Sales Charge: 0.50%

The maximum sales charge for investors in fee accounts consists of the creation and development fee. Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges apply to units purchased as an ineligible asset.

The creation and development fee is a charge of $.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the creation and development fee will be less than 0.50%; if the price you pay is less than $10.00 per unit, the creation and development fee will exceed 0.50%.

In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.

Risk Considerations:

An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market. In addition, the portfolio is heavily weighted in only a few stocks, making it more volatile than an equally weighted portfolio.

An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

You should be aware that the portfolio is concentrated in stocks in both the consumer products and health care sectors which involves additional risks, including limited diversification. The companies engaged in the consumer products industry are subject to global competition, changing government regulations and trade policies, currency fluctuations, and the financial and political risks inherent in producing products for foreign markets. The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends. In addition, the Health Care and Education Affordability Reconciliation Act of 2010 has had and will continue to have a significant impact on the health care sector.

An investment in a portfolio containing equity securities of foreign issuers is subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting foreign issuers.

One of the securities held by the trust is issued by a REIT. Companies involved in the real estate industry are subject to changes in the real estate market, vacancy rates and competition, volatile interest rates and economic recession.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cyber security.

“Value Line”, “The Value Line Investment Survey”, and “Timeliness” are trademarks or registered trademarks of Value Line, Inc. (“Value Line”) and have been licensed for use for certain purposes by First Trust Portfolios L.P. and First Trust Advisors L.P. This product is not sponsored, endorsed, recommended, sold or promoted by Value Line and Value Line makes no representation regarding the advisability of investing in products utilizing such strategy. First Trust Portfolios L.P. and First Trust Advisors L.P. are not affiliated with any Value Line company.

Fund Cusip Information
30297W181 (Cash)
30297W199 (Reinvest)
30297W207 (Cash-Fee)
30297W215 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial advisors are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2019 All rights reserved.